Well I'm going against the current line of thought.
My bet is on Pre Clinical results, ie the work that has been done on Alzheimer's and possibly other neurological stuff show exciting possibilities for the use of MonePantel in that space. Which would confirm Dr Thurns vision of seeing PAA as Global leaders in the neoro area in the not to distant future which he states toward the end of this presentation
Hopefully resulting in a SP kick then a CR.
Good luck to all
Ann: Trading Halt, page-24
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 17.0¢ | 15.5¢ | $145.3K | 876.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38307 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 302337 | 3 |
View Market Depth
| Last trade - 15.51pm 23/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |